GIPC Report Shows Negative Impacts of Drug Pricing Controls on Patient Access to Treatments

“This report finds, in part, that an innovation framework in which drug R&D is supported by private patents, without government price intervention, provides the best possible environment for patients to access new treatments. I am revealing to.” Today, the Global…








